Výsledky vyhledávání - "Bianca Jc van den Bosch"

Potential added value of combined DPYD/DPD genotyping and phenotyping to prevent severe toxicity in patients with a DPYD variant and decreased dihydropyrimidine dehydrogenase enzyme activity

Autor: Jörgen Bierau, Marieke J H Coenen, Judith de Vos-Geelen, Charlotte W. Ockeloen, Bianca Jc van den Bosch, Manon Hijmans-van der Vegt, Annelieke Ecab Willemsen, Aron Raaijmakers

Publikováno v: Journal of Oncology Pharmacy Practice, 29, 5-13
Journal of Oncology Pharmacy Practice, 29(1):10781552211049144, 5-13. SAGE Publications Inc.
Journal of Oncology Pharmacy Practice, 29, 1, pp. 5-13
Journal of Oncology Pharmacy Practice, 29(1), 5-13. SAGE Publications Ltd

Decreased dihydropyrimidine dehydrogenase enzyme activity is associated with severe fluoropyrimidine-associated toxicity. Four clinically relevant variants in the DPYD gene are associated with decreased dihydropyrimidine dehydrogenase activity. Howev

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33feca5e57b760a3acc28fad217b0173
https://doi.org/10.1177/10781552211049144

Zobrazit plný text záznamu

Potential added value of combined DPYD/DPD genotyping and phenotyping to prevent severe toxicity in patients with a

Autor: Charlotte W, Ockeloen, Aron, Raaijmakers, Manon, Hijmans-van der Vegt, Jörgen, Bierau, Judith, de Vos-Geelen, Annelieke Ecab, Willemsen, Bianca Jc, van den Bosch, Marieke Jh, Coenen

Publikováno v: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 29(1)

To investigate if dihydropyrimidine dehydrogenase phenotyping has added value when combined withRetrospective cohort study in which treatment and toxicity data were collected of 228 patients genotyped for fourSevere toxicity occurred in 25% of patien

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::30e7a81ba952259471da317a45d863ab
https://pubmed.ncbi.nlm.nih.gov/34797200

Zobrazit plný text záznamu

Akademický článek

Potential added value of combined DPYD/DPD genotyping and phenotyping to prevent severe toxicity in patients with a DPYD variant and decreased dihydropyrimidine dehydrogenase enzyme activity.

Autor: Ockeloen, Charlotte W, Raaijmakers, Aron, Hijmans-van der Vegt, Manon, Bierau, Jörgen, de Vos-Geelen, Judith, Willemsen, Annelieke ECAB, van den Bosch, Bianca JC, Coenen, Marieke JH

Publikováno v: Journal of Oncology Pharmacy Practice; Jan2023, Vol. 29 Issue 1, p5-13, 9p

Zobrazit plný text záznamu

sj-docx-1-opp-10.1177_10781552211049144 - Supplemental material for Potential added value of combined DPYD/DPD genotyping and phenotyping to prevent severe toxicity in patients with a DPYD variant and decreased dihydropyrimidine dehydrogenase enzyme activity

Autor: Ockeloen, Charlotte W, Raaijmakers, Aron, Hijmans-van der Vegt, Manon, Bierau, J��rgen, de Vos-Geelen, Judith, Willemsen, Annelieke ECAB, van den Bosch, Bianca JC, Coenen, Marieke JH

Supplemental material, sj-docx-1-opp-10.1177_10781552211049144 for Potential added value of combined DPYD/DPD genotyping and phenotyping to prevent severe toxicity in patients with a DPYD variant and decreased dihydropyrimidine dehydrogenase enzyme a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::329944f1ac233340d57a0494ed1de81c

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání